Medical Animation Lupus

Researchers Uncover Biological Rationale For Why Intensive Lupus Treatment Works
Researchers at UT Southwestern Medical Center have uncovered the biological rationale for why large doses of corticosteroids given repeatedly over several weeks may help individuals with lupus, a chronic inflammatory disease that affects more than 1 million people in the U.S...

Human Genome Sciences And Lonza Enter Commercial Manufacturing Agreement For BENLYSTA(R), A Potential New Treatment For Systemic Lupus Erythematosus
Human Genome Sciences, Inc. (Nasdaq:HGSI) and Lonza announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE)...

New Research Uncovers Why Many With Lupus Are Resistant To Traditional Treatments
Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today. It is estimated that more than 5 million people suffer from lupus worldwide...

People With Lupus Denied Health Insurance Due To Pre-Existing Condition May Be Able To Obtain Coverage Through Health Care Reform Law Plan
President Obama signed the Health Care Reform package in to law in March 2010, which will extend insurance coverage to as many as 32 million Americans who currently do not have health insurance, as well as provide much-needed protections for people with lupus and other chronic conditions...

Research Presented At The 9th International Lupus Congress Provides Hope And Encouragement For The Future Treatment And Management Of Lupus
Research presented during the 9th International Lupus Congress held in Vancouver, Canada from June 24-27, 2010 should give hope and encouragement for the future of the treatment and management of lupus to the 1.5 million Americans and 5 million people worldwide living with lupus...

Oxidative And Nitrosative Stress Contribute To Lupus Disease Activity
University of Texas Medical Branch researchers have uncovered an association between free radical-mediated reactions and the severity and progression of system lupus erythematosus (SLE). Higher levels of oxidative and nitrosative stress markers were found in SLE patients with greater disease activity suggesting a causal relationship...

Clinical Differences In Systemic Lupus Erythmatosus Patients May Be Affected By Genealogy
The effects of Systemic Lupus Erythematosus (SLE) may differ based on the individual patient's genealogical heritage, according to results of a new study presented at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. In particular, the study reinforced differences in SLE phenotype found between Northern and Southern European subpopulations...

Chinese Systemic Lupus Erythematosus Data Reveal Differences In Epidemiology Across Continents
The Chinese Systemic Lupus Erythematosus (SLE) Treatment and Research Group (CSTAR) announced interim epidemiological information on SLE patients in China at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Robust data on SLE patients has been scarce to date; but now CSTAR provides the first online registry of this magnitude in China...

Rheumatoid Arthritis And SLE Negatively Affect The Sex Lives Of Patients
Systemic Lupus Erythematosus (SLE) patients from Brazil and Rheumatoid Arthritis (RA) patients from France report that their rheumatic conditions negatively affect their emotional relationships and sex lives, according to research presented at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy...

The LFA To Report On The Latest News From The International Lupus Congress
Representatives and staff from the Lupus Foundation of America (LFA) are headed to the International Lupus Congress, which will be held from June 24-27 in Vancouver, Canada. This triennial meeting brings together physicians and researchers to share the latest developments in lupus...

NATURE Publishes New Dynavax Findings On Novel Role Of TLRs In Lupus
Dynavax Technologies Corporation (NASDAQ: DVAX) today reported in NATURE new data that may explain the resistance of lupus patients to glucocorticoid treatment. In the June 16, 2010 issue of NATURE, Dynavax scientists show that activation of cells of the innate immune system by two key receptors, TLR7 and TLR9, can cause glucocorticoid resistance in lupus patients...

New Data Shows Epratuzumab Provided Significant Efficacy For Patients With Moderate To Severe Systemic Lupus Erythematosus
UCB (EURONEXT: UCB) and Immunomedics Inc. (NASDAQ:IMMU) announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE)...

New Data Presented From EMBLEM™ Study For Pipeline Drug Epratuzumab For Patients Suffering From Moderate To Severe Systemic Lupus Erythematosus
UCB (Euronext: UCB) and Immunomedics, Inc. (Nasdaq: IMMU) announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE)...

Lupus Foundation Of America Says Results Of Latest Study Of CellCept Provide Encouragement And Hope For People With Lupus Nephritis
The Lupus Foundation of America praised the results of a new long-term study for the treatment of lupus nephritis (lupus-related kidney disease) which demonstrated superiority of CellCept® (mycophenolate mofetil or MMF) to azathioprine (standard care) as a long-term treatment for lupus nephritis...

"Borderline Positive For Lupus" - What Does That Mean?
During a recent interview on Larry King Live on CNN, singer Lady Gaga stated that she tested borderline positive for lupus but that, as of right now, she does not have lupus. There are many challenges in confirming whether a person has lupus. Lupus symptoms can be unclear, can come and go, and can change over time...